Back to all studies
🫃
Phase 2
Gastrointestinal
in-person
Efficacy of Rifaximin With NAC in IBS-D
Sponsored by Mark Pimentel, MD
Compensation
$500–$2,500
Duration
3 months
Location
California
About this study
The purpose of this study is to examine the effectiveness of using a combination of a drug, rifaximin and a dietary supplement, N-acetyl-L-cysteine (NAC), to treat patients with irritable bowel syndrome with diarrhea (IBS-D). Rifaximin is one of the standard treatments for IBS-D and is FDA approved. While rifaximin is safe and effective for treating symptoms in patients with IBS-D, many patients find that their symptoms may not completely resolve, or may come back after a period of time. This…
Who can participate
- • Adults aged 18–99
- • All genders welcome
- • Diagnosed with or experiencing ibs (irritable bowel syndrome)
- • Able to attend in-person clinic visits
What's included
- • Compensation up to $2,500
- • All study-related medical care at no cost
- • Lab work, screenings, and physician consultations
- • Study medication or treatment provided
IRB-approved study. Free to apply. Your information is kept confidential.
Ready to Find a Paid Study?
Join over 100,000 people who have been matched with clinical studies. It's free, fast, and could change your life.